Pharvaris NV (PHVS)
22.60
-0.93
(-3.95%)
USD |
NASDAQ |
May 03, 16:00
23.17
+0.57
(+2.52%)
After-Hours: 20:00
Pharvaris Price to Book Value: 2.937 for May 3, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| May 02, 2024 | 2.987 |
| May 01, 2024 | 3.115 |
| April 30, 2024 | 3.117 |
| April 29, 2024 | 2.973 |
| April 26, 2024 | 2.96 |
| April 25, 2024 | 2.886 |
| April 24, 2024 | 2.694 |
| April 23, 2024 | 2.699 |
| April 22, 2024 | 2.646 |
| April 19, 2024 | 2.429 |
| April 18, 2024 | 2.335 |
| April 17, 2024 | 2.688 |
| April 16, 2024 | 2.662 |
| April 15, 2024 | 2.554 |
| April 12, 2024 | 2.776 |
| April 11, 2024 | 2.828 |
| April 10, 2024 | 2.823 |
| April 09, 2024 | 2.933 |
| April 08, 2024 | 2.883 |
| April 05, 2024 | 2.860 |
| April 04, 2024 | 2.843 |
| April 03, 2024 | 2.826 |
| April 02, 2024 | 2.808 |
| April 01, 2024 | 2.743 |
| March 28, 2024 | 2.928 |
| Date | Value |
|---|---|
| March 27, 2024 | 2.978 |
| March 26, 2024 | 3.002 |
| March 25, 2024 | 2.694 |
| March 22, 2024 | 3.085 |
| March 21, 2024 | 3.168 |
| March 20, 2024 | 3.159 |
| March 19, 2024 | 3.293 |
| March 18, 2024 | 3.146 |
| March 15, 2024 | 2.959 |
| March 14, 2024 | 3.000 |
| March 13, 2024 | 2.978 |
| March 12, 2024 | 2.992 |
| March 11, 2024 | 2.988 |
| March 08, 2024 | 3.354 |
| March 07, 2024 | 3.341 |
| March 06, 2024 | 3.249 |
| March 05, 2024 | 3.069 |
| March 04, 2024 | 2.943 |
| March 01, 2024 | 3.061 |
| February 29, 2024 | 2.907 |
| February 28, 2024 | 2.982 |
| February 27, 2024 | 3.012 |
| February 26, 2024 | 3.063 |
| February 23, 2024 | 3.365 |
| February 22, 2024 | 3.422 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.3676
Minimum
Dec 02 2022
11.26
Maximum
Feb 25 2021
3.027
Average
2.571
Median
Price to Book Value Benchmarks
| uniQure NV | 1.079 |
| ProQR Therapeutics NV | 3.592 |
| Merus NV | 7.939 |
| argenx SE | 5.637 |
| Pharming Group | 3.078 |
Price to Book Value Related Metrics
| Price | 22.60 |
| Earnings Yield | -9.28% |
| Market Cap | 1.216B |